The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA

A. Daliry, M. Q. Pires, C. F. Silva, R. S. Pacheco, M. Munde, C. E. Stephens, A. Kumar, M. A. Ismail, Z. Liu, A. A. Farahat, S. Akay, P. Som, Q. Hu, D. W. Boykin, W. D. Wilson, S. L. De Castro, M. N.C. Soeiro

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Due to limited efficacy and considerable toxicity, the therapy for Chagas' disease is far from being ideal, and thus new compounds are desirable. Diamidines and related compounds such as arylimidamides have promising trypanocidal activity against Trypanosoma cruzi. To better understand the mechanism of action of these heterocyclic cations, we investigated the kinetoplast DNA (kDNA) binding properties and trypanocidal efficacy against T. cruzi of 13 compounds. Four diamidines (DB75, DB569, DB1345, and DB829), eight arylimidamides (DB766, DB749, DB889, DB709, DB613, DB1831, DB1852, and DB2002), and one guanylhydrazone (DB1080) were assayed in thermal denaturation (T m) and circular dichroism (CD) studies using whole purified T. cruzi kDNA and a conserved synthetic parasite sequence. The overall CD spectra using the whole kDNA were similar to those found for the conserved sequence and were indicative of minor groove binding. Our findings showed that some of the compounds that exhibited the highest trypanocidal activities (e.g., DB766) caused low or no change in the T m measurements. However, while some active compounds, such as DB766, induced profound alterations of kDNA topology, others, like DB1831, although effective, did not result in altered T m and CD measurements. Our data suggest that the strong affinity of amidines with kDNA per se is not sufficient to generate and trigger their trypanocidal activity. Cell uptake differences and possibly distinct cellular targets need to be considered in the final evaluation of the mechanisms of action of these compounds.

Original languageEnglish (US)
Pages (from-to)4765-4773
Number of pages9
JournalAntimicrobial Agents and Chemotherapy
Volume55
Issue number10
DOIs
StatePublished - Oct 1 2011

Fingerprint

Kinetoplast DNA
Amidines
Trypanosoma cruzi
Circular Dichroism
Pentamidine
Chagas Disease
Conserved Sequence
Cations
Parasites
Hot Temperature

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA. / Daliry, A.; Pires, M. Q.; Silva, C. F.; Pacheco, R. S.; Munde, M.; Stephens, C. E.; Kumar, A.; Ismail, M. A.; Liu, Z.; Farahat, A. A.; Akay, S.; Som, P.; Hu, Q.; Boykin, D. W.; Wilson, W. D.; De Castro, S. L.; Soeiro, M. N.C.

In: Antimicrobial Agents and Chemotherapy, Vol. 55, No. 10, 01.10.2011, p. 4765-4773.

Research output: Contribution to journalArticle

Daliry, A, Pires, MQ, Silva, CF, Pacheco, RS, Munde, M, Stephens, CE, Kumar, A, Ismail, MA, Liu, Z, Farahat, AA, Akay, S, Som, P, Hu, Q, Boykin, DW, Wilson, WD, De Castro, SL & Soeiro, MNC 2011, 'The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA', Antimicrobial Agents and Chemotherapy, vol. 55, no. 10, pp. 4765-4773. https://doi.org/10.1128/AAC.00229-11
Daliry, A. ; Pires, M. Q. ; Silva, C. F. ; Pacheco, R. S. ; Munde, M. ; Stephens, C. E. ; Kumar, A. ; Ismail, M. A. ; Liu, Z. ; Farahat, A. A. ; Akay, S. ; Som, P. ; Hu, Q. ; Boykin, D. W. ; Wilson, W. D. ; De Castro, S. L. ; Soeiro, M. N.C. / The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA. In: Antimicrobial Agents and Chemotherapy. 2011 ; Vol. 55, No. 10. pp. 4765-4773.
@article{926e648fbf5b41b5b2d16c2575e16478,
title = "The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA",
abstract = "Due to limited efficacy and considerable toxicity, the therapy for Chagas' disease is far from being ideal, and thus new compounds are desirable. Diamidines and related compounds such as arylimidamides have promising trypanocidal activity against Trypanosoma cruzi. To better understand the mechanism of action of these heterocyclic cations, we investigated the kinetoplast DNA (kDNA) binding properties and trypanocidal efficacy against T. cruzi of 13 compounds. Four diamidines (DB75, DB569, DB1345, and DB829), eight arylimidamides (DB766, DB749, DB889, DB709, DB613, DB1831, DB1852, and DB2002), and one guanylhydrazone (DB1080) were assayed in thermal denaturation (T m) and circular dichroism (CD) studies using whole purified T. cruzi kDNA and a conserved synthetic parasite sequence. The overall CD spectra using the whole kDNA were similar to those found for the conserved sequence and were indicative of minor groove binding. Our findings showed that some of the compounds that exhibited the highest trypanocidal activities (e.g., DB766) caused low or no change in the T m measurements. However, while some active compounds, such as DB766, induced profound alterations of kDNA topology, others, like DB1831, although effective, did not result in altered T m and CD measurements. Our data suggest that the strong affinity of amidines with kDNA per se is not sufficient to generate and trigger their trypanocidal activity. Cell uptake differences and possibly distinct cellular targets need to be considered in the final evaluation of the mechanisms of action of these compounds.",
author = "A. Daliry and Pires, {M. Q.} and Silva, {C. F.} and Pacheco, {R. S.} and M. Munde and Stephens, {C. E.} and A. Kumar and Ismail, {M. A.} and Z. Liu and Farahat, {A. A.} and S. Akay and P. Som and Q. Hu and Boykin, {D. W.} and Wilson, {W. D.} and {De Castro}, {S. L.} and Soeiro, {M. N.C.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1128/AAC.00229-11",
language = "English (US)",
volume = "55",
pages = "4765--4773",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA

AU - Daliry, A.

AU - Pires, M. Q.

AU - Silva, C. F.

AU - Pacheco, R. S.

AU - Munde, M.

AU - Stephens, C. E.

AU - Kumar, A.

AU - Ismail, M. A.

AU - Liu, Z.

AU - Farahat, A. A.

AU - Akay, S.

AU - Som, P.

AU - Hu, Q.

AU - Boykin, D. W.

AU - Wilson, W. D.

AU - De Castro, S. L.

AU - Soeiro, M. N.C.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Due to limited efficacy and considerable toxicity, the therapy for Chagas' disease is far from being ideal, and thus new compounds are desirable. Diamidines and related compounds such as arylimidamides have promising trypanocidal activity against Trypanosoma cruzi. To better understand the mechanism of action of these heterocyclic cations, we investigated the kinetoplast DNA (kDNA) binding properties and trypanocidal efficacy against T. cruzi of 13 compounds. Four diamidines (DB75, DB569, DB1345, and DB829), eight arylimidamides (DB766, DB749, DB889, DB709, DB613, DB1831, DB1852, and DB2002), and one guanylhydrazone (DB1080) were assayed in thermal denaturation (T m) and circular dichroism (CD) studies using whole purified T. cruzi kDNA and a conserved synthetic parasite sequence. The overall CD spectra using the whole kDNA were similar to those found for the conserved sequence and were indicative of minor groove binding. Our findings showed that some of the compounds that exhibited the highest trypanocidal activities (e.g., DB766) caused low or no change in the T m measurements. However, while some active compounds, such as DB766, induced profound alterations of kDNA topology, others, like DB1831, although effective, did not result in altered T m and CD measurements. Our data suggest that the strong affinity of amidines with kDNA per se is not sufficient to generate and trigger their trypanocidal activity. Cell uptake differences and possibly distinct cellular targets need to be considered in the final evaluation of the mechanisms of action of these compounds.

AB - Due to limited efficacy and considerable toxicity, the therapy for Chagas' disease is far from being ideal, and thus new compounds are desirable. Diamidines and related compounds such as arylimidamides have promising trypanocidal activity against Trypanosoma cruzi. To better understand the mechanism of action of these heterocyclic cations, we investigated the kinetoplast DNA (kDNA) binding properties and trypanocidal efficacy against T. cruzi of 13 compounds. Four diamidines (DB75, DB569, DB1345, and DB829), eight arylimidamides (DB766, DB749, DB889, DB709, DB613, DB1831, DB1852, and DB2002), and one guanylhydrazone (DB1080) were assayed in thermal denaturation (T m) and circular dichroism (CD) studies using whole purified T. cruzi kDNA and a conserved synthetic parasite sequence. The overall CD spectra using the whole kDNA were similar to those found for the conserved sequence and were indicative of minor groove binding. Our findings showed that some of the compounds that exhibited the highest trypanocidal activities (e.g., DB766) caused low or no change in the T m measurements. However, while some active compounds, such as DB766, induced profound alterations of kDNA topology, others, like DB1831, although effective, did not result in altered T m and CD measurements. Our data suggest that the strong affinity of amidines with kDNA per se is not sufficient to generate and trigger their trypanocidal activity. Cell uptake differences and possibly distinct cellular targets need to be considered in the final evaluation of the mechanisms of action of these compounds.

UR - http://www.scopus.com/inward/record.url?scp=80052834047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052834047&partnerID=8YFLogxK

U2 - 10.1128/AAC.00229-11

DO - 10.1128/AAC.00229-11

M3 - Article

C2 - 21807972

AN - SCOPUS:80052834047

VL - 55

SP - 4765

EP - 4773

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 10

ER -